Fighting infectious diseases with immunotherapy on ‘cusp of commercialization’ – Genetic Literacy Project
Genetic Literacy Project |
Fighting infectious diseases with immunotherapy on 'cusp of commercialization'
Genetic Literacy Project Pharmaceutical firms have invested billions of dollars in cancer immunotherapies over the last few years, and the US Food and Drug Administration (FDA) began approving such therapies in recent months. But the investment bonanza has yet to hit antiviral … |
